NCT00005674
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Washington University St Louis, Missouri, United States
Clinical trial condition
Amyotrophic Lateral Sclerosis
Explore clinical trials studying Amyotrophic Lateral Sclerosis. Study availability and eligibility vary by location and protocol.
707 public trials
173 recruiting studies
Amyotrophic Lateral Sclerosis trial results
NCT00004771
- Conditions
- Amyotrophic Lateral Sclerosis, Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, +23 more
- Locations
-
Not specified
NCT00005766
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- University of Vermont Burlington, Vermont, United States
Active, Not Recruiting
Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)
NCT07204977
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Frontotemporal Dementia With Motor Neuron Disease, +9 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Active, Not Recruiting
HEALEY ALS Platform Trial - Master Protocol
NCT04297683
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Barrow Neurological Institute Phoenix, Arizona, United States
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- UC San Diego La Jolla, California, United States
Active, Not Recruiting
FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)
NCT04768972
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- University of California San Diego La Jolla, California, United States
- Stanford University Medical Center Palo Alto, California, United States
- Johns Hopkins University Baltimore, Maryland, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
Active, Not Recruiting
HEALEY ALS Platform Trial - Regimen I NUZ-001
NCT07410806
- Conditions
- Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
- Locations
-
- Healey Center for ALS at Massachusetts General Hospital Boston, Massachusetts, United States
Active, Not Recruiting
Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier Disruption in Amyotrophic Lateral Sclerosis (ALS)
NCT07193953
- Conditions
- ALS, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
- Locations
-
- Sunnybrook Health Sciences Centre Toronto, Ontario, Canada
Active, Not Recruiting
Personalized Antisense Oligonucleotide for a Single Participant With CHCHD10 ALS
NCT06977451
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Columbia University, Irving Medical Center New York, United States
Active, Not Recruiting
Personalized Antisense Oligonucleotide Therapy for A Single Participant With CHCHD10 ALS
NCT06392126
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Mayo Clinic Jacksonville, Florida, United States